0001144204-19-009921.txt : 20190225
0001144204-19-009921.hdr.sgml : 20190225
20190225173501
ACCESSION NUMBER: 0001144204-19-009921
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190219
FILED AS OF DATE: 20190225
DATE AS OF CHANGE: 20190225
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hallberg Dane
CENTRAL INDEX KEY: 0001768844
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-13341
FILM NUMBER: 19630726
MAIL ADDRESS:
STREET 1: 400 OYSTER POINT BLVD., SUITE 505
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TITAN PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000910267
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 943171940
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 400 OYSTER POINT BLVD
STREET 2: SUITE 505
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 6502444990
MAIL ADDRESS:
STREET 1: 400 OYSTER POINT BLVD
STREET 2: SUITE 505
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94080
3
1
tv514640_3.xml
OWNERSHIP DOCUMENT
X0206
3
2019-02-19
0
0000910267
TITAN PHARMACEUTICALS INC
TTNP
0001768844
Hallberg Dane
400 OYSTER POINT BLVD., SUITE 505
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
See Remarks
Option (Right to Buy)
1.26
2028-10-01
Common Stock
41667
D
The option vests in 48 equal monthly installments commencing November 1, 2018.
Executive Vice President and Chief Commercial Officer
/s/Dane Hallberg
2019-02-25